Hydroxychloroquine Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the hydroxychloroquine market looks promising with opportunities in hospitals and clinics. The global hydroxychloroquine market is expected to grow with a CAGR of 33%-35% from 2020 to 2025. The major growth drivers for this market are the recent outbreak of viruses, such as coronavirus disease (COVID-19); increasing incidence of malaria in developing countries; and rising autoimmune diseases, such as rheumatoid arthritis and lupus erythematosus.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global hydroxychloroquine market report, please download the report brochure.
In this market, 400 mg is the largest dosage type segment of hydroxychloroquine, whereas development of COVID-19 is the largest application. Growth in various segments of the hydroxychloroquine market are given below:
The study includes trends and forecast for the global hydroxychloroquine market by dosage type, sales channel, application, and region as follows:
By Dosage Type [Value ($ Million) shipment analysis for 2014 – 2025]:
200 mg
400 mg
800 mg
By Sales Channel [Value ($ Million) shipment analysis for 2014 – 2025]:
Online
Offline
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Coronavirus Disease (COVID-19)
Malaria
Rheumatoid Arthritis
Lupus Erythematosus
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the hydroxychloroquine companies profiled in this report include Novartis, Amneal Pharmaceuticals, Laurus Labs, Prasco Laboratories, Cardinal Health, Advanz Pharma, Dr. Reddy's Laboratories, Covis Pharmaceuticals, Mylan, and McKesson.
Lucintel forecasts that 400 mg will remain the largest dosage type segment over the forecast period due to increasing prevalence of autoimmune diseases and malaria.
Within this market, COVID-19 will remain the highest growing application segment over the forecast period due to rapidly increasing cases of COVID-19 all over the world.
Asia Pacific will remain the largest region over the forecast period due to rising cases of maleria, rapidly increasing cases of COVID-19, and presence of major pharmaceutical manufacturing units in the region.
Features of the Global Hydroxychloroquine Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global hydroxychloroquine market by dosage type (200 mg, 400 mg, and 800 mg), sales channel (online and offline), application (COVID-19, malaria, rheumatoid arthritis, lupus erythematosus, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global hydroxychloroquine market?
Q.5 What are the business risks and threats to the global hydroxychloroquine market?
Q.6 What are the emerging trends in this hydroxychloroquine market and the reasons behind them?
Q.7 What are some changing demands of customers in this hydroxychloroquine market?
Q.8 What are the new developments in this hydroxychloroquine market? Which companies are leading these developments?
Q.9 Who are the major players in this hydroxychloroquine market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this hydroxychloroquine market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global hydroxychloroquine market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Dosage Type (200 Mg, 400 Mg, and 800 Mg), Sales Channel (Online and Offline), and Application (COVID-19, Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the hydroxychloroquine market looks promising with opportunities in hospitals and clinics. The global hydroxychloroquine market is expected to grow with a CAGR of 33%-35% from 2020 to 2025. The major growth drivers for this market are the recent outbreak of viruses, such as coronavirus disease (COVID-19); increasing incidence of malaria in developing countries; and rising autoimmune diseases, such as rheumatoid arthritis and lupus erythematosus.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global hydroxychloroquine market report, please download the report brochure.
In this market, 400 mg is the largest dosage type segment of hydroxychloroquine, whereas development of COVID-19 is the largest application. Growth in various segments of the hydroxychloroquine market are given below:
The study includes trends and forecast for the global hydroxychloroquine market by dosage type, sales channel, application, and region as follows:
By Dosage Type [Value ($ Million) shipment analysis for 2014 – 2025]:
200 mg
400 mg
800 mg
By Sales Channel [Value ($ Million) shipment analysis for 2014 – 2025]:
Online
Offline
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Coronavirus Disease (COVID-19)
Malaria
Rheumatoid Arthritis
Lupus Erythematosus
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the hydroxychloroquine companies profiled in this report include Novartis, Amneal Pharmaceuticals, Laurus Labs, Prasco Laboratories, Cardinal Health, Advanz Pharma, Dr. Reddy's Laboratories, Covis Pharmaceuticals, Mylan, and McKesson.
Lucintel forecasts that 400 mg will remain the largest dosage type segment over the forecast period due to increasing prevalence of autoimmune diseases and malaria.
Within this market, COVID-19 will remain the highest growing application segment over the forecast period due to rapidly increasing cases of COVID-19 all over the world.
Asia Pacific will remain the largest region over the forecast period due to rising cases of maleria, rapidly increasing cases of COVID-19, and presence of major pharmaceutical manufacturing units in the region.
Features of the Global Hydroxychloroquine Market
- Market Size Estimates: Global hydroxychloroquine market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global hydroxychloroquine market size by various segments, such as dosage type, sales channel, and application in terms of value.
- Regional Analysis: Global hydroxychloroquine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different dosage type, sales channel, application, and region for the global hydroxychloroquine market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global hydroxychloroquine market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global hydroxychloroquine market by dosage type (200 mg, 400 mg, and 800 mg), sales channel (online and offline), application (COVID-19, malaria, rheumatoid arthritis, lupus erythematosus, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global hydroxychloroquine market?
Q.5 What are the business risks and threats to the global hydroxychloroquine market?
Q.6 What are the emerging trends in this hydroxychloroquine market and the reasons behind them?
Q.7 What are some changing demands of customers in this hydroxychloroquine market?
Q.8 What are the new developments in this hydroxychloroquine market? Which companies are leading these developments?
Q.9 Who are the major players in this hydroxychloroquine market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this hydroxychloroquine market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global hydroxychloroquine market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Dosage Type (200 Mg, 400 Mg, and 800 Mg), Sales Channel (Online and Offline), and Application (COVID-19, Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Hydroxychloroquine Market Trends and Forecast
3.3: Global Hydroxychloroquine Market by Dosage Type
3.3.1: 200mg
3.3.2: 400mg
3.3.3: 800mg
3.4: Global Hydroxychloroquine Market by Sales Channel
3.4.1: Online
3.4.2: Offline
3.5: Global Hydroxychloroquine Market by Application
3.5.1: Coronavirus Disease (COVID 19)
3.5.2: Malaria
3.5.3: Rheumatoid Arthritis
3.5.4: Lupus Erythematosus
3.5.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Hydroxychloroquine Market by Region
4.2: North American Hydroxychloroquine Market
4.2.1: Market by Dosage Type: 200mg, 400mg, and 800mg
4.2.2: Market by Sales Channel: Online and Offline
4.2.3: Market by Application: Coronavirus Disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others
4.2.4: The United States Hydroxychloroquine Market
4.2.5: The Canadian Hydroxychloroquine Market
4.2.6: The Mexican Hydroxychloroquine Market
4.3: European Hydroxychloroquine Market
4.3.1: Market by Dosage Type: 200mg, 400mg, and 800mg
4.3.2: Market by Sales Channel: Online and Offline
4.3.3: Market by Application: Coronavirus Disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others
4.3.4: The Hydroxychloroquine Market of United Kingdom
4.3.5: The German Hydroxychloroquine Market
4.3.6: The French Hydroxychloroquine Market
4.4: APAC Hydroxychloroquine Market
4.4.1: Market by Dosage Type: 200mg, 400mg, and 800mg
4.4.2: Market by Sales Channel: Online and Offline
4.4.3: Market by Application: Coronavirus Disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others
4.4.4: The Chinese Hydroxychloroquine Market
4.4.5: The Indian Hydroxychloroquine Market
4.4.6: The Japanese Hydroxychloroquine Market
4.5: ROW Hydroxychloroquine Market
4.5.1: Market by Dosage Type: 200mg, 400mg, and 800mg
4.5.2: Market by Sales Channel: Online and Offline
4.5.3: Market by Application: Coronavirus Disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others
4.5.4: Brazilian Hydroxychloroquine Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Hydroxychloroquine Market by Dosage Type
7.1.2: Growth Opportunities for the Global Hydroxychloroquine Market by Sales Channel
7.1.3: Growth Opportunities for the Global Hydroxychloroquine Market by Application
7.1.4: Growth Opportunities for the Global Hydroxychloroquine Market by Region
7.2: Emerging Trends in the Global Hydroxychloroquine Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Hydroxychloroquine Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hydroxychloroquine Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Novartis International AG
8.2: Amneal Pharmaceuticals, Inc.
8.3: Laurus Labs Ltd.
8.4: Prasc Laboratories
8.5: Cardinal Health, Inc.
8.6: Advanz Pharma Corporation
8.7: Dr. Reddy's Laboratories, Ltd.
8.8: Covis Pharmaceuticals Inc.
8.9: Mylan N.V.
8.10: McKesson Corporation
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Hydroxychloroquine Market Trends and Forecast
3.3: Global Hydroxychloroquine Market by Dosage Type
3.3.1: 200mg
3.3.2: 400mg
3.3.3: 800mg
3.4: Global Hydroxychloroquine Market by Sales Channel
3.4.1: Online
3.4.2: Offline
3.5: Global Hydroxychloroquine Market by Application
3.5.1: Coronavirus Disease (COVID 19)
3.5.2: Malaria
3.5.3: Rheumatoid Arthritis
3.5.4: Lupus Erythematosus
3.5.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Hydroxychloroquine Market by Region
4.2: North American Hydroxychloroquine Market
4.2.1: Market by Dosage Type: 200mg, 400mg, and 800mg
4.2.2: Market by Sales Channel: Online and Offline
4.2.3: Market by Application: Coronavirus Disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others
4.2.4: The United States Hydroxychloroquine Market
4.2.5: The Canadian Hydroxychloroquine Market
4.2.6: The Mexican Hydroxychloroquine Market
4.3: European Hydroxychloroquine Market
4.3.1: Market by Dosage Type: 200mg, 400mg, and 800mg
4.3.2: Market by Sales Channel: Online and Offline
4.3.3: Market by Application: Coronavirus Disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others
4.3.4: The Hydroxychloroquine Market of United Kingdom
4.3.5: The German Hydroxychloroquine Market
4.3.6: The French Hydroxychloroquine Market
4.4: APAC Hydroxychloroquine Market
4.4.1: Market by Dosage Type: 200mg, 400mg, and 800mg
4.4.2: Market by Sales Channel: Online and Offline
4.4.3: Market by Application: Coronavirus Disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others
4.4.4: The Chinese Hydroxychloroquine Market
4.4.5: The Indian Hydroxychloroquine Market
4.4.6: The Japanese Hydroxychloroquine Market
4.5: ROW Hydroxychloroquine Market
4.5.1: Market by Dosage Type: 200mg, 400mg, and 800mg
4.5.2: Market by Sales Channel: Online and Offline
4.5.3: Market by Application: Coronavirus Disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others
4.5.4: Brazilian Hydroxychloroquine Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Hydroxychloroquine Market by Dosage Type
7.1.2: Growth Opportunities for the Global Hydroxychloroquine Market by Sales Channel
7.1.3: Growth Opportunities for the Global Hydroxychloroquine Market by Application
7.1.4: Growth Opportunities for the Global Hydroxychloroquine Market by Region
7.2: Emerging Trends in the Global Hydroxychloroquine Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Hydroxychloroquine Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hydroxychloroquine Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Novartis International AG
8.2: Amneal Pharmaceuticals, Inc.
8.3: Laurus Labs Ltd.
8.4: Prasc Laboratories
8.5: Cardinal Health, Inc.
8.6: Advanz Pharma Corporation
8.7: Dr. Reddy's Laboratories, Ltd.
8.8: Covis Pharmaceuticals Inc.
8.9: Mylan N.V.
8.10: McKesson Corporation
